John Hussman's TARS Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 16,800 shares of Tarsus Pharmaceuticals, Inc. (TARS) worth $1.38 M, representing 0.33% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 2 quarters.
Based on recent 13F filings, John Hussman has initiated a new position in TARS, representing a fresh investment thesis on this company. Largest reduction occurred in Q4 2025, reducing 14,700 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's Tarsus Pharmaceuticals (TARS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tarsus Pharmaceuticals (TARS) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -14,700 | Reduce 46.67% | 16,800 | $81.88 |
| Q3 2025 | +31,500 | New Buy | 31,500 | $59.43 |
John Hussman's Tarsus Pharmaceuticals Investment FAQs
John Hussman first purchased Tarsus Pharmaceuticals, Inc. (TARS) in Q3 2025, acquiring 31,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held Tarsus Pharmaceuticals, Inc. (TARS) for 2 quarters since Q3 2025.
John Hussman's largest addition to Tarsus Pharmaceuticals, Inc. (TARS) was in Q3 2025, adding 31,500 shares worth $1.87 M.
According to the latest 13F filing for Q4 2025, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 16,800 shares of Tarsus Pharmaceuticals, Inc. (TARS), valued at approximately $1.38 M.
As of the Q4 2025 filing, Tarsus Pharmaceuticals, Inc. (TARS) represents approximately 0.33% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in Tarsus Pharmaceuticals, Inc. (TARS) was 31,500 shares, as reported at the end of Q3 2025.